ANZ News
Funded by the Queensland government, a University of Queensland project is developing a VR program for practising safe falls for the first time among patients with spinal cord injury.
Also, Wellumio has received $4 million in pre-Series A funding to further develop its portable, AI-augmented brain scanner.
Extensive clinical validation and deployment are what remain to make it routine, according to University of New South Wales Scientia Professor Justin Gooding.
Also, Omniscient Neurotechnology has received $14 million in government-backed funding to scale its AI-based brain mapping platform.
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.
The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.
Screening rates in northern Queensland lag behind the statewide average.
The model can also make zero-shot predictions.
It demonstrated over 90% accuracy in detecting binary foetal movements in a hospital trial.